CYC · Cyclopharm Limited

0.52

AUD

-0.03 (-4.59%)

24/06/2026 04:10:09 PM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$65.55M

190.00

EV/EBITDA

N/A

DIV Yield

0%

Franking

0%

MQV Rating

5Very Weak

As at 24/06/2026 04:10:09 PM

Price Chart

Description

Cyclopharm Ltd. is a radiopharmaceutical company, which engages in diagnostic imaging in lung health. It manufactures and sells medical devices and pharmaceutical products. It operates through Technegas and Molecular Imaging segments. The Technegas segment supplies diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment produces radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease. The company was founded in 1984 and is headquartered in Kingsgrove, Australia.

All-Companies
All-Consensus
Consensus Cheap
GROWTH AUS
HALO Ords
Near Support (Realtime)
Volume Spike

Key Fundamentals

EPS 3 yr Growth

118.10%

EBITDA Margin

-50.80%

Operating Cashflow

-$17m

Free Cash Flow Return

-40.90%

ROIC

-40.70%

Interest Coverage

-26.20

Quick Ratio

1.50

Performance

52 weeks range

Low 0.52 - 1.29

Trade Value (12mth)

AU$17,619.00

1 week

-0.91%

1 month

-23.24%

YTD

-44.67%

1 year

-38.07%

All time high

3.45

Additional Data

Shares Outstanding (Fully Diluted)

111m

HALO Sector

Healthcare

Next Company Report Date

24-Feb-27

Next Ex Dividend Date

01-Sep-23

Next Dividend Pay Date

11-Sep-23

Reporting Currency

AUD

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Very Strong

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

Date	Event
08 May 26ASXD
08 May 26ASXD
08 May 26ASXD
08 May 26ASXD
08 May 26ASXD

Related Companies

View all

CSL · CSL Limited

114.99AU$

RMD · ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

27.93AU$

SIG · Sigma Healthcare Ltd

2.73AU$

CYC · Cyclopharm Limited

0.52

Overview

AU$65.55M

190.00

N/A

0%

0%

5Very Weak

Price Chart

Description

Key Fundamentals

Performance

Additional Data

Consensus

Health Scores

Short Term

Halo Model

Momentum

Growth

Quality

Valuation

News & Announcements

Related Companies

See beyond the curve.